Anzeige
Mehr »
Dienstag, 24.02.2026 - Börsentäglich über 12.000 News
Von Polen bis Virginia Beach- zündet hier der nächste Smallcap-Turbo?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 936039 | ISIN: CA8667961053 | Ticker-Symbol: LIE
Tradegate
23.02.26 | 19:08
54,50 Euro
-0,91 % -0,50
1-Jahres-Chart
SUN LIFE FINANCIAL INC Chart 1 Jahr
5-Tage-Chart
SUN LIFE FINANCIAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
54,5055,0013:21
54,5055,0007:30
PR Newswire
79 Leser
Artikel bewerten:
(0)

Sun Life to proactively offer second opinions on cancer diagnoses when members file a cancer-related claim

Expert Cancer Review services help boost members' confidence in their cancer treatment plan

WELLESLEY, Mass., Feb. 23, 2026 /PRNewswire/ -- Sun Life U.S. is expanding access to its Expert Cancer Review (ECR) service by proactively engaging members closer to the time of diagnosis. When a member files a cancer-related claim for disability or critical illness/cancer (supplemental health) insurance, Sun Life will reach out to connect them to ECR services available through their employers' Sun Life stop-loss policy. Members must also be enrolled in Sun Life disability or supplemental benefits.

ECR provides members diagnosed with cancer an objective, documented second opinion from an independent oncology specialist, helping to ensure they get the right care and feel confident in their chosen treatment plan. From 2024 - 2025, 41% of the second opinions facilitated by Sun Life resulted in a change in diagnosis or shift in diagnostic strategy or treatment.

"Offering a second opinion when our members file a cancer-related claim for disability or critical illness/cancer benefits enables us to support them closer to the time of their diagnosis," said Joi Tillman, president, Group Benefits, Sun Life U.S. "Expert Cancer Review will help members feel more confident in their treatment while their Sun Life disability and supplemental health plans replace their income and pay cash benefits to help them cover out-of-pocket costs. This is a great next step in integrating our Health and Risk Solutions services with our Group Benefits member experience, following the initial expansion of our Health Navigator personal care advisor services last year."

Cancer continues to be one of the most frequently diagnosed and costliest diseases to treat in the U.S. According to Sun Life's 2025 High Cost Claims Report, the average annual cost of a cancer claim ranged from about $235,000 for malignant neoplasm ("solid" cancers) to over $300,000 for leukemia, lymphoma, and multiple myeloma (blood cancers). While ECR is already available through an employer's Sun Life medical stop-loss policy, members can now receive proactive outreach when filing a cancer-related disability or supplemental health claim with Sun Life - engaging them earlier in the process, when the expert second opinion can be more valuable to the member.

According to the National Institute of Health, cancer diagnoses have become more prevalent in those under age 50 - people still in the workforce. Sun Life's High Cost Claims Report showed that solid cancers, particularly in adults ages 40-59, made up more than 40% of the total medical spend across Sun Life's stop-loss claims for 2024. As more people in the workforce encounter cancer diagnoses, employee benefits can play a pivotal role in increasing access to care and support.

"Expert second opinions on cancer can avoid misdiagnoses and spare people unnecessary treatments, as well as lead to better, more tailored therapies," said Jen Collier, president, Health and Risk Solutions, Sun Life U.S. "More efficient and effective care also drives down costs, which benefits both the member and their employer. Proactively connecting eligible members to ECR will support our employer clients as they help their employees stay at or return to work, and drive better health outcomes overall."

Sun Life has continuously evolved its approach to benefits integration to better support those with cancer. In addition to offering healthcare navigation and ECR, Sun Life automatically screens a member for critical illness/cancer benefits when there is a stop-loss (high-dollar) claim filed for cancer. If they are covered, the member receives their benefit payment without needing to file a separate claim.

ECR is facilitated by Sun Life Health Navigator, a service that provides personal health advisors who help people get the right care, doctors and treatment to support them through their medical journey. Second opinions are an integral part of Health Navigator services, whether for cancer or other diagnoses.

To learn more about impacts of cancer in the workforce and the support of Sun Life benefits, visit www.sunlife.com/cancer.

About Sun Life
Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the U.S., the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of December 31, 2025, Sun Life had total assets under management of C$1.6 trillion. For more information, please visit www.sunlife.com.

Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.

Sun Life U.S. is one of the largest providers of employee and government benefits, helping approximately 50 million Americans access the care and coverage they need. Through employers, industry partners and government programs, Sun Life U.S. offers a portfolio of benefits and services, including dental, vision, disability, absence management, life, supplemental health, medical stop-loss insurance, and healthcare navigation. Sun Life employs more than 8,300 people in the U.S., including associates in our partner dental practices and affiliated companies in asset management. Group insurance policies are issued by Sun Life Assurance Company of Canada (Wellesley Hills, Mass.), except in New York, where policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, Mich.). For more information visit our website and newsroom.

Media contacts

Devon Fernald
Sun Life U.S.
[email protected]
781-800-3609

Connect with Sun Life U.S.

Facebook LinkedIn

SOURCE Sun Life U.S.

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.